CRISPR Therapeutics AG

CRSP · Healthcare · · USD

53.35 USD

0.00 (-5.31%)

● Updated 2026-07-11 20:15 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score SELL Short-term (Swing)

/ 100

Technical 25

Trend & RS 39

Momentum 49

Fundamental (0%) 48

Macro 75

Liquidity 47

Component	Score	Weight
Technical	25.0	40%
Trend & RS	38.9	20%
Momentum	48.9	20%
Fundamental	47.9	0%
Macro	74.8	15%
Liquidity	46.9	5%

Trade Setup

Entry	53.35
Stop Loss	46.45 (12.9%)
Target 1 (1:1)	60.25 (+12.9%)
Target 2 (2:1)	67.15 (+25.9%)

ATR(14)	3.45 (6.5%)
Risk per Share	6.90
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	75.4	+1.02
Momentum	48.9	-0.04
Quality	40.0	-0.40
Composite	54.8

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 3.12 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	2.8	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

25.65%

Full Kelly

12.83%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 41/100. Estimated win rate 52%, avg win 7.5%, avg loss 4.2%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG SELL

Bullish Signals

Bearish Signals

45.94

RSI(14)

1.3243

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (-8.2% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (4d since high)
Sector Outperformance	+2.7% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	45.94	NEUTRAL
Macd	1.3243	BEARISH
Ma Cross	53.29 / 55.49	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		BELOW SMA200
Bollinger		MIDDLE
Volume	1.2x	NORMAL

Key Levels

Level	Price
52-Week High	78.48
Bollinger Upper	61.6
SMA(200)	55.49
SMA(50)	53.29
SMA(20)	55.04
Current Price	53.35
Bollinger Lower	48.48
52-Week Low	44.12
ATR(14)	3.45

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

Insufficient data for Wyckoff analysis.

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	1.19x	Normal bar — no special VSA pattern
2026-07-07	Normal	0.96x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.71x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.83x	Normal bar — no special VSA pattern
2026-07-10	Normal	1.2x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	57.75	Above Kijun
Kijun-sen (26)	56.23	Base line
Senkou A	56.99	Leading span A
Senkou B	55.19	Leading span B
Cloud	55.19 – 56.99	Bullish (Green)
Price vs Cloud	53.35	Below Cloud
Chikou Span	52.08	Bullish
Alignment Score	3/4	NEUTRAL